Ropirio Therapeutics, Inc.
Company

Ropirio Therapeutics, Inc.

Biotechnology Research This Need Is Immense 4 employees
Employees
4
Contacts
2
Emails
2
Phones
2

Ropirio Therapeutics, Inc. Overview

Headquarters
This Need Is Immense
Industry
Biotechnology Research
Employees
4
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Ropirio Therapeutics, Inc.

Over the past decade, there has been an explosion of research uncovering the critical role the lymphatic system plays in serious diseases affecting more than 500 million people globally. The opportunity to address this need is immense, and Ropirio is at the forefront, having identified the first target that activates the lymphatic system. This activation improves lymphatic flow, modulates inflammation, and prevents fibrosis. Ropirio is singularly focused on developing the first lymphatic medicines to improve patients’ lives.

Ropirio Therapeutics, Inc. Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage
Phone contacts
2
100.0% coverage

Ropirio Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Sangeeta Bhatia Mit Professor & Entrepreneur
Email Phone
Jerald Korn CEO at Ropirio Therapeutics
Email Phone

Compare Similar Companies to Ropirio Therapeutics, Inc.